Credit Suisse’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-55,593
| Closed | -$4.18M | – | 4511 |
|
|
2022
Q2 | $4.18M | Sell |
55,593
-805,813
| -94% | -$60.6M | ﹤0.01% | 1393 |
|
|
2022
Q1 | $23.1M | Sell |
861,406
-669
| -0.1% | -$18K | 0.02% | 700 |
|
|
2021
Q4 | $41.1M | Sell |
862,075
-4,748
| -0.5% | -$226K | 0.02% | 538 |
|
|
2021
Q3 | $57.6M | Buy |
866,823
+4,425
| +0.5% | +$294K | 0.03% | 428 |
|
|
2021
Q2 | $67.3M | Buy |
862,398
+53,636
| +7% | +$4.18M | 0.04% | 393 |
|
|
2021
Q1 | $76.5M | Sell |
808,762
-2,600
| -0.3% | -$246K | 0.04% | 389 |
|
|
2020
Q4 | $98.9M | Buy |
811,362
+255,604
| +46% | +$31.1M | 0.05% | 288 |
|
|
2020
Q3 | $48.6M | Sell |
555,758
-1,171
| -0.2% | -$102K | 0.03% | 440 |
|
|
2020
Q2 | $36M | Buy |
556,929
+193,988
| +53% | +$12.5M | 0.03% | 526 |
|
|
2020
Q1 | $16.2M | Buy |
362,941
+155,259
| +75% | +$6.93M | 0.01% | 734 |
|
|
2019
Q4 | $12.9M | Buy |
+207,682
| New | +$12.9M | 0.01% | 954 |
|